FOLH1 and posterior cortical atrophy: In 2016, 64Cu-labeled PSMA-617 became the first 64Cu-labeled ligand for PET imaging of PCa patients and was investigated at two nuclear medicine centers (Vienna, Austria, and Bed Berka, Germany) [53].